A biophysical insight into the RANTES-glycosaminoglycan interaction

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 4, 2009, Pages 577-582

  Rek, Angelika ^a   Brandner, Barbara ^b   Geretti, Elena ^b   Kungl, Andreas J ^a,b  

^a ProtAffin Biotechnologie AG   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chemokine; Circular dichroism; Fluorescence spectroscopy; Heparan sulfate; Heparin

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; RANTES;

ANISOTROPY; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; FLUORESCENCE ANALYSIS; IN VIVO STUDY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION;

CELL LINE, TUMOR; CHEMOKINE CCL5; CHEMOTAXIS; CIRCULAR DICHROISM; ESCHERICHIA COLI; FLUORESCENCE POLARIZATION; HEPARITIN SULFATE; HUMANS; KINETICS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SODIUM CHLORIDE; SURFACE PLASMON RESONANCE;

EID: 61649128742     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.01.001     Document Type: Article

References (42)

1. Ward S.G., and Westwick J. Chemokines: understanding their role in T-lymphocyte biology. Biochem. J. 333 (1998) 457-470
2. Cascieri M.A., and Springer M.S. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr. Opin. Chem. Biol. 4 (2000) 420-427
3. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
4. Baggiolini M. Chemokines in pathology and medicine. J. Intern. Med. 250 (2001) 91-104
5. Baggiolini M., Loetscher P., and Moser B. Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17 (1995) 103-108
6. Maghazachi A.A. Intracellular signaling events at the leading edge of migrating cells. Int. J. Biochem. Cell Biol. 32 (2000) 931-943
7. Appay V., and Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 22 (2001) 83-87
8. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine 3 (1991) 165-183
9. Vila-Coro A.J., Mellado M., Martin de Ana A., Martinez-A. C., and Rodriguez-Frade J.M. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex. J. Immunol. 163 (1999) 3037-3044
10. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13 (1992) 291-294
11. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
12. Handel T.M., Johnson Z., Crown S.E., Lau E.K., and Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
13. Jackson D.G. Human leukocyte heparan sulphate proteoglycans and their roles in inflammation. Biochem. Soc. Trans. 25 (1997) 220-224
14. Sasisekharan R., and Venkataraman G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4 (2000) 626-631
15. Esko J.D., and Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108 (2001) 169-173
16. Turnbull J., Powell A., and Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11 (2001) 75-82
17. Johnson Z., Proudfoot A.E., and Handel T.M. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 16 6 (2005) 625-636
18. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., Wells T.N., and Proudfoot A.E. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173 9 (2004) 5776-5785 1
19. Mbemba E., Slimani H., Atemezem A., Saffar L., and Gattegno L. Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells. Biochim. Biophys. Acta 1510 (2001) 354-366
20. Proudfoot A.E., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., and Wells T.N. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 (2001) 10620-10626
21. Hileman R.E., Fromm J.R., Weiler J.M., and Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20 (1998) 156-167
22. Campanella G.S., Lee E.M., Sun J., and Luster A.D. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278 (2003) 17066-17074
23. Murooka T.T., Wong M.M., Rahbar R., Majchrzak-Kita B., Proudfoot A.E., and Fish E.N. CCL5-CCR5-mediated apoptosis in T cells: requirement for glycosaminoglycan binding and CCL5 aggregation. J. Biol. Chem. 281 35 (2006) 25184-25194
24. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12 (1994) 593-633
25. Rollins B.J. Chemokines. Blood 90 (1997) 909-928
26. Mack M., Luckow B., Nelson P.J., Cihak J., Simmons G., Clapham P.R., Signoret N., Marsh M., Stangassinger M., Borlat F., Wells T.N., Schlondorff D., and Proudfoot A.E. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187 (1998) 1215-1224
27. Appay V., Brown A., Cribbes S., Randle E., and Czaplewski L.G. Aggregation of RANTES is responsible for its inflammatory properties. J. Biol. Chem. 274 (1999) 27505-27512
28. Trkola A., Gordon C., Matthews J., Maxwell E., Ketas T., Czaplewski L., Proudfoot A.E., and Moore J.P. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73 (1999) 6370-6379
29. Goger B., Halden Y., Rek A., Mösl R., Pye D., Gallagher J., and Kungl A.J. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41 (2002) 1640-1646
30. Falsone S.F., Kurkela R., Chiarandini G., Vihko P., and Kungl A.J. Ligand affinity, homodimerization, and ligand-induced secondary structural change of the human vitamin D receptor. Biochem. Biophys. Res. Comm. 285 (2001) 1180-1185
31. Falsone F.S., Weichel M., Crameri R., Breitenbach M., and Kungl A.J. Unfolding and double-stranded DNA binding of the cold shock protein homologue Cla h 8 from Cladosporium herbarum. J. Biol. Chem. 277 (2002) 16512-16516
32. Laguri C., Sadir R., Rueda P., Baleux F., Gans P., Arenzana-Seisdedos F., and Lortat-Jacob H. The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS ONE 2 10 (2007) e1110
33. Sreerama N., and Woody R.W. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem. 209 (1993) 32-44
34. Margeat E., Poujol N., Boulahtouf A., Chen Y., Muller J.D., Gratton E., Cavailles V., and Royer C.A. The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure. J. Mol. Biol. 306 (2001) 433-442
35. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., and Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochem. 36 (1997) 13570-13578
36. Vivès R.R., Sadir R., Imberty A., Rencurosi A., and Lortat-Jacob H. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41 (2002) 14779-14789
37. Shubsda M.F., Paoletti A.C., Hudson B.S., and Borer P.N. Affinities of packaging domain loops in HIV-1 RNA for the nucleocapsid protein. Biochem. 41 (2002) 5276-5282
38. Zasedateleva O.A., Krylov A.S., Prokopenko D.V., Skabkin M.A., Ovchinnikov L.P., Kolchinsky A., and Mirzabekov A.D. Specificity of mammalian Y-box binding protein p50 in interaction with ss and ds DNA analyzed with generic oligonucleotide microchip. J. Mol. Biol. 324 (2002) 73-87
39. Thompson L.D., Pantoliano M.W., and Springer B.A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochem. 33 (1994) 3831-3840
40. Skelton N.J., Aspiras F., Ogez J., and Schall T.J. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochem. 34 (1995) 5329-5342
41. Shaw J.P., Kryger G., Cleasby A., Wonacott A., Power C.A., Proudfoot A.E., and Wells T.N. Crystallization and preliminary X-ray diffraction studies of human RANTES. J. Mol. Biol. 242 (1994) 589-590
42. Proudfoot A., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N.C., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1885-1890